{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ATC|ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|IMMUNOSTIMULANTS" in comments (approximate match)
Status:
US Approved Rx
(2014)
Source:
BLA125499
(2014)
Source URL:
First approved in 2014
Source:
BLA125499
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2022)
Source:
BLA761173
(2022)
Source URL:
First approved in 2002
Source:
BLA125031
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2002)
Source:
BLA103964
(2002)
Source URL:
First approved in 2002
Source:
BLA103964
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2001)
Source:
BLA103949
(2001)
Source URL:
First approved in 2001
Source:
BLA103949
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(1996)
Source:
BLA103628
(1996)
Source URL:
First approved in 1996
Source:
BLA103628
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(1993)
Source:
BLA103471
(1993)
Source URL:
First approved in 1993
Source:
BLA103471
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(1992)
Source:
BLA103293
(1992)
Source URL:
First approved in 1992
Source:
BLA103293
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(1991)
Source:
BLA103362
(1991)
Source URL:
First approved in 1991
Source:
BLA103362
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2018)
Source:
BLA761080
(2018)
Source URL:
First approved in 1991
Source:
BLA103353
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(1986)
Source:
BLA103132
(1986)
Source URL:
First approved in 1986
Source:
BLA103132
Source URL:
Class:
PROTEIN
